Profitability Strong, Confidence Under Pressure
Roche’s profitability remains best-in-class (ROIC 31.7%, margin 30%), but market confidence is unsettled after a 19% EPS miss and analyst downgrades. Core capital returns are intact. The main stress centers on earnings volatility and cautious sentiment. A more stable outlook would require steadier EPS delivery and improved regulatory momentum.
Published by AssetNext · 2026-04-20
Break down ROG.SW's structural position across all peer dimensions with the interactive app.